These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36835324)

  • 1. Pathogenicity of Type I Interferons in
    Mundra A; Yegiazaryan A; Karsian H; Alsaigh D; Bonavida V; Frame M; May N; Gargaloyan A; Abnousian A; Venketaraman V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to
    Weindel CG; Bell SL; Vail KJ; West KO; Patrick KL; Watson RO
    Elife; 2020 Feb; 9():. PubMed ID: 32057291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy.
    Watson RO; Bell SL; MacDuff DA; Kimmey JM; Diner EJ; Olivas J; Vance RE; Stallings CL; Virgin HW; Cox JS
    Cell Host Microbe; 2015 Jun; 17(6):811-819. PubMed ID: 26048136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III interferons in innate and adaptive immunity in the respiratory tract.
    Piperakis A; Galani IE; Andreakos E
    Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.
    Travar M; Petkovic M; Verhaz A
    Arch Immunol Ther Exp (Warsz); 2016 Feb; 64(1):19-31. PubMed ID: 26362801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferons in infectious disease.
    McNab F; Mayer-Barber K; Sher A; Wack A; O'Garra A
    Nat Rev Immunol; 2015 Feb; 15(2):87-103. PubMed ID: 25614319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages.
    Novikov A; Cardone M; Thompson R; Shenderov K; Kirschman KD; Mayer-Barber KD; Myers TG; Rabin RL; Trinchieri G; Sher A; Feng CG
    J Immunol; 2011 Sep; 187(5):2540-7. PubMed ID: 21784976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis.
    Moreira-Teixeira L; Stimpson PJ; Stavropoulos E; Hadebe S; Chakravarty P; Ioannou M; Aramburu IV; Herbert E; Priestnall SL; Suarez-Bonnet A; Sousa J; Fonseca KL; Wang Q; Vashakidze S; Rodríguez-Martínez P; Vilaplana C; Saraiva M; Papayannopoulos V; O'Garra A
    Nat Commun; 2020 Nov; 11(1):5566. PubMed ID: 33149141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
    Jafarzadeh A; Nemati M; Saha B; Bansode YD; Jafarzadeh S
    Viral Immunol; 2021 Jun; 34(5):307-320. PubMed ID: 33147113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type I interferon and bacterial infection].
    Diao R; Xu F; Wang XD
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):464-8. PubMed ID: 22927085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.
    Chin KL; Anis FZ; Sarmiento ME; Norazmi MN; Acosta A
    J Immunol Res; 2017; 2017():5212910. PubMed ID: 28713838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
    Andreakos E; Zanoni I; Galani IE
    Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNγ-mediated autophagy and growth restriction of intracellular mycobacteria.
    Lienard J; Movert E; Valfridsson C; Sturegård E; Carlsson F
    Cell Microbiol; 2016 Oct; 18(10):1471-85. PubMed ID: 27062290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferons in tuberculosis: Foe and occasionally friend.
    Moreira-Teixeira L; Mayer-Barber K; Sher A; O'Garra A
    J Exp Med; 2018 May; 215(5):1273-1285. PubMed ID: 29666166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1.
    Wassermann R; Gulen MF; Sala C; Perin SG; Lou Y; Rybniker J; Schmid-Burgk JL; Schmidt T; Hornung V; Cole ST; Ablasser A
    Cell Host Microbe; 2015 Jun; 17(6):799-810. PubMed ID: 26048138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin 6 in innate immunity to Mycobacterium tuberculosis infection.
    Martinez AN; Mehra S; Kaushal D
    J Infect Dis; 2013 Apr; 207(8):1253-61. PubMed ID: 23359591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.